Hosted on MSN1h
Novartis and Dawn Health introduce breast cancer support appInitially launching in Germany, the app will soon be available in the UK, Australia, Canada, and other markets.
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...
One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.
GlobalData on MSN13h
ScreenPoint’s AI breast cancer screening tool hits detection success in new studyScreenPoint Medical found that its Transpara AI tool increased cancer detection by 29% and reduced radiologist read times by ...
The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...
Compared with endocrine therapy, radiotherapy was associated with a smaller reduction in health-related quality-of-life in ...
The first official version of the European quality assurance scheme for breast cancer services is now available on the European Commission web hub.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback